Federico Mingozzi | Chief Scientific Officer
Spark Therapeutics

Federico Mingozzi, Chief Scientific Officer, Spark Therapeutics


Conference Day 1 - Tuesday 31st March 2020 @ 17:20

Panel discussion: Immunogenicity for gene therapy

Key unresolved clinical issues in gene therapy: immunosuppression, re-dosing, and in-utero dosing

Conference Day 2 - Wednesday 1st April 2020 @ 09:00

Gene therapy 2.0: New clinical data, therapeutic applications and next generation technologies

  • Latest updates on LUXTURNA studies to treat blindness, haemophilia and rare disease
  • Tackling the challenges of viral gene therapies i.e. immunogenicity
  • Developing the next generation of gene therapies, what does the future hold?
last published: 03/Aug/20 09:25 GMT

back to speakers